Pulling SEC filings + quote and writing the call…
Pulling SEC filings + quote and writing the call…

MKS INC
Next earnings Aug 4, 2026 (after close) · consensus $3.01 EPS, $1.23B rev
Last earnings +2.1% on 2026-05-06
Real earnings recovery, but a 93x P/E on a leveraged single-digit-margin cyclical leaves no margin of safety.
Sources: SEC EDGAR (CIK 0001049502, latest 10-Q filed 2026-05-07) · EODHD · analysis by claude-code · as of 6/21/2026, 7:05:21 PM.
Research and education only — not financial advice. Calls are generated from SEC filings and a delayed/third-party price feed, may be wrong or out of date, and are not a recommendation to buy or sell any security. Do your own research.
Weak on both the fundamentals and the price — little to like at the current level.
MKS is executing a genuine operational recovery. FY2025 revenue grew 9.6% to $3.93B, net income jumped 55.3% to $295M and diluted EPS rose 55.5% to $4.37, with operating cash flow up 22.2% to $645M and a clean PCAOB audit opinion (including effective internal controls). After the FY2023 net loss of $1.84B, the trajectory is clearly improving and the balance sheet is healing — stockholders' equity grew 17.1% to $2.72B and long-term debt fell 7.5% to $4.15B. So the quality concern is not solvency; it is valuation versus the kind of business this is.
The risks, catalysts, 12-month price target and the cited SEC figures behind this rating — with Pro.
Unlock with Pro€15/mo · cancel anytime
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | $2.95B | $3.55B | $3.62B | $3.59B | $3.93B |
| Gross profit | $1.38B | $1.55B | $1.64B | $1.71B | $1.84B |
| Operating income | $699M | $617M | -$1.55B | $498M | $528M |
| Net income | $551M | $333M | -$1.84B | $190M | $295M |
| Diluted EPS | $9.90 | $5.56 | -$27.54 | $2.81 | $4.37 |
| Net margin | 18.7% | 9.4% | -50.8% | 5.3% | 7.5% |
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
Disclosed under the STOCK Act
Self-reported periodic transaction reports (STOCK Act). Amounts are disclosed ranges; a trade may be a spouse's. Disclosures lag the trade by up to ~45 days. Source: House Clerk + Senate eFD.
1482 tracked peers · median
Source: EODHD. Yield = trailing-12-month dividends ÷ price.
Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.
Recent news tone vs the market's typical (which skews positive). A soft signal, not a recommendation.
Last 90 days: 0 open-market buys · 16 sales
| 2026-06-12 | Schreiner James Alan EVP & COO | Sell | 2.47K @ $345.52 | $854K |
| 2026-06-12 | Schreiner James Alan EVP & COO | Sell | 812.00 @ $346.41 | $281K |
| 2026-06-12 | Schreiner James Alan EVP & COO | Sell | 217.00 @ $347.00 | $75.3K |
| 2026-06-10 | Schreiner James Alan EVP & COO | Sell | 781.00 @ $317.42 | $248K |
| 2026-06-05 | McCarthy Michelle M SVP & Chief Accounting Officer | Sell | 2.43K @ $315.23 | $767K |
| 2026-06-01 | Henry David Philip EVP, Global Str Mktg & GM, MSD | Sell | 6.00K @ $314.43 | $1.89M |
| 2026-06-01 | Mora Elizabeth Director | Sell | 300.00 @ $318.02 | $95.4K |
| 2026-05-27 | Donahue Joseph B Director | Sell | 2.10K @ $327.95 | $689K |
| 2026-05-27 | COLELLA GERALD G Director | Sell | 464.00 @ $330.38 | $153K |
| 2026-05-27 | COLELLA GERALD G Director | Sell | 8.21K @ $331.45 | $2.72M |
| 2026-05-27 | COLELLA GERALD G Director | Sell | 4.88K @ $332.04 | $1.62M |
| 2026-05-27 | COLELLA GERALD G Director | Sell | 1.81K @ $335.46 | $608K |